drugset / Trial / NCT01890629
Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare efficacy and safety of initial combination therapy of Gemigliptin versus Sitagliptin or Glimepiride with Metformin on Glucose Variability(MAGE, Glucose SD) in Patients With Type 2 Diabetes Mellitus.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemigliptin | Small molecule | 50 mg | — |
| Subject | Glimepiride | Small molecule | 2 mg | — |
| Subject | Sitagliptin | Small molecule | 100 mg | — |
| Background | Metformin | Small molecule | 500 mg | — |
| Background | Metformin | Small molecule | 1000 mg | — |